go back

Melanoma Versus Benign Mole Gene Test

Delaware rates for HCPCS 0314U

Helps decide whether a skin lesion is a melanoma or a harmless mole when its appearance under the microscope is not clear cut. The activity of 35 genes is measured in the stored tissue sample and the lesion is classified accordingly. A companion test instead judges the outlook for squamous cell skin cancers.

Rates data updated July 2026.

Facilitymedian $2,239 · 10th–90th $2,239$2,2390%50%100%$2,239Professionalmedian $1,023 · 10th–90th $1,023$1,6220%20%40%90th$1,023$1.0K$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,238.72
Median
$2,238.72
Typical High
$2,238.72
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,023.29
Median
$1,023.29
Typical High
$1,621.81
United
Setting
Professional
Modifier
Global
Typical Low
$812.83
Median
$1,174.90
Typical High
$2,951.21